These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 3290263

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Amiloride for the prevention of amphotericin B-induced hypokalemia and hypomagnesemia.
    Wazny LD, Brophy DF.
    Ann Pharmacother; 2000 Jan; 34(1):94-7. PubMed ID: 10669191
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comment: spironolactone prevents amphotericin B-induced hypokalemia in neutropenic patients.
    Ural AU.
    Ann Pharmacother; 2000 Dec; 34(12):1488. PubMed ID: 11144711
    [No Abstract] [Full Text] [Related]

  • 6. Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome)--a report on 40 cases from a single centre.
    Chopra R, Fielding A, Goldstone AH.
    Leuk Lymphoma; 1992 Dec; 7 Suppl():73-7. PubMed ID: 1493462
    [Abstract] [Full Text] [Related]

  • 7. Occurrence and improvement of renal dysfunction and serum potassium abnormality during administration of liposomal amphotericin B in patients with hematological disorders: A retrospective analysis.
    Yamazaki H, Kondo T, Aoki K, Yamashita K, Takaori-Kondo A.
    Diagn Microbiol Infect Dis; 2018 Feb; 90(2):123-131. PubMed ID: 29203252
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK.
    Flynn TN, Kelsey SM, Hazel DL, Guest JF.
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):543-50. PubMed ID: 10662479
    [Abstract] [Full Text] [Related]

  • 11. Safety and toxicity of amphotericin B in glucose 5% or intralipid 20% in neutropenic patients with pneumonia or fever of unknown origin: randomised study.
    Schöffski P, Freund M, Wunder R, Petersen D, Köhne CH, Hecker H, Schubert U, Ganser A.
    BMJ; 1998 Aug 08; 317(7155):379-84. PubMed ID: 9694753
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Incidence and treatment of fungal infections in neutropenic patients.
    von Paleske A, Müllerleile U, Gressler V, Garbrecht M, Hossfeld DK.
    Haematol Blood Transfus; 1987 Aug 08; 30():545-6. PubMed ID: 3476385
    [No Abstract] [Full Text] [Related]

  • 14. Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients.
    Moreau P, Milpied N, Fayette N, Ramée JF, Harousseau JL.
    J Antimicrob Chemother; 1992 Oct 08; 30(4):535-41. PubMed ID: 1490923
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A prospective randomized trial of central venous catheter removal versus intravenous amphotericin B in febrile neutropenic patients.
    Lazarus HM, Lowder JN, Anderson JM, Herzig RH.
    JPEN J Parenter Enteral Nutr; 1984 Oct 08; 8(5):501-5. PubMed ID: 6541714
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.